Clinical Trial Update: TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation [Phase 2]

View source ↗

Summary

The Cleveland Clinic is conducting a Phase 2 study to evaluate tirzepatide for obesity in patients with atrial fibrillation, and the trial is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Atrial Fibrillation, Obesity | Phase 2 | Status: RECRUITING